Literature DB >> 6903572

Feedback regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase in livers of mice treated with mevinolin, a competitive inhibitor of the reductase.

T Kita, M S Brown, J L Goldstein.   

Abstract

Compactin (ML-236B) and the related compound, mevinolin, are competitive inhibitors of 3-hydroxy-3-methylglutaryl coenzyme A reductase (HMG CoA reductase), the rate-controlling enzyme in cholesterol synthesis. Previous studies have shown that administration of compactin to cultured cells elicits a compensatory increase in the amount of HMG CoA reductase in the cells. A similar increase in HMG CoA reductase has been reported in livers of rats and mice that have been treated with compactin. In this study, we explore the mechanism for the mevinolin-mediated increase in hepatic HMG CoA reductase in mice that have been fed a control diet and a 2% cholesterol diet. Administration of mevinolin to mice on a control diet produced a 6- to 10-fold increase in the amount of HMG CoA reductase in liver microsomes. When mice were fed the cholesterol-enriched diet, cholesterol accumulated in the liver and HMG CoA reductase declined by 90%. The administration of mevinolin to cholesterol-fed mice produced a three to eightfold increase in HMG CoA reductase. Despite the abundant amount of cholesterol that was already present in the livers of the mevinolin-treated, cholesterol-fed animals, their elevated HMG CoA reductase could be rapidly suppressed by the subcutaneous injection of small amounts of mevalonate, the product of HMG CoA reductase. These data are compatible with the existence in mouse liver of a multivalent feedback regulatory mechanism for HMG CoA reductase in which suppression of the enzyme requires both a sterol and a nonsterol substance derived from mevalonate. By blocking mevalonate synthesis, mevinolin activates this regulatory mechanism, and this in turn causes an increase in hepatic HMG CoA reductase. The ability to suppress the elevated HMG CoA reductase with mevalonate may prove useful in potentiating the effectiveness of mevinolin as a hypocholesterolemic agent.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6903572      PMCID: PMC371547          DOI: 10.1172/JCI109938

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  18 in total

1.  Inhibition of cholesterol synthesis with compactin renders growth of cultured cells dependent on the low density lipoprotein receptor.

Authors:  J L Goldstein; J A Helgeson; M S Brown
Journal:  J Biol Chem       Date:  1979-06-25       Impact factor: 5.157

Review 2.  Reversible modulation of liver hydroxymethylglutaryl CoA reductase.

Authors:  D M Gibson; T S Ingebritsen
Journal:  Life Sci       Date:  1978-12-31       Impact factor: 5.037

3.  Role of the low density lipoprotein receptor in regulating the content of free and esterified cholesterol in human fibroblasts.

Authors:  M S Brown; J R Faust; J L Goldstein
Journal:  J Clin Invest       Date:  1975-04       Impact factor: 14.808

4.  Crystal and molecular structure of compactin, a new antifungal metabolite from Penicillium brevicompactum.

Authors:  A G Brown; T C Smale; T J King; R Hasenkamp; R H Thompson
Journal:  J Chem Soc Perkin 1       Date:  1976

5.  Interconversion of active and inactive forms of rat liver hydroxymethylglutaryl-CoA reductase.

Authors:  J L Nordstrom; V W Rodwell; J J Mitschelen
Journal:  J Biol Chem       Date:  1977-12-25       Impact factor: 5.157

6.  Active and inactive forms of 3-hydroxy-3-methylglutaryl coenzyme A reductase in the liver of the rat. Comparison with the rate of cholesterol synthesis in different physiological states.

Authors:  M S Brown; J L Goldstein; J M Dietschy
Journal:  J Biol Chem       Date:  1979-06-25       Impact factor: 5.157

7.  Induction of 3-hydroxy-3-methylglutaryl coenzyme A reductase activity in human fibroblasts incubated with compactin (ML-236B), a competitive inhibitor of the reductase.

Authors:  M S Brown; J R Faust; J L Goldstein; I Kaneko; A Endo
Journal:  J Biol Chem       Date:  1978-02-25       Impact factor: 5.157

8.  Inhibitory effects on lipid metabolism in cultured cells of ML-236B, a potent inhibitor of 3-hydroxy-3-methylglutaryl-coenzyme-A reductase.

Authors:  I Kaneko; Y Hazama-Shimada; A Endo
Journal:  Eur J Biochem       Date:  1978-06-15

9.  Control of 3-hydroxy-3-methylglutaryl coenzyme A reductase by endogenously synthesized sterols in vitro and in vivo.

Authors:  P A Edwards; G Popják; A M Fogelman; J Edmond
Journal:  J Biol Chem       Date:  1977-02-10       Impact factor: 5.157

10.  3-Hydroxy-3-methylglutaryl coenzyme A reductase: regulation of enzymatic activity by phosphorylation and dephosphorylation.

Authors:  Z H Beg; J A Stonik; H B Brewer
Journal:  Proc Natl Acad Sci U S A       Date:  1978-08       Impact factor: 11.205

View more
  86 in total

1.  Farnesol-induced cell death and stimulation of 3-hydroxy-3-methylglutaryl-coenzyme A reductase activity in tobacco cv bright yellow-2 cells.

Authors:  A Hemmerlin; T J Bach
Journal:  Plant Physiol       Date:  2000-08       Impact factor: 8.340

2.  Floral odor bouquet loses its ant repellent properties after inhibition of terpene biosynthesis.

Authors:  Robert R Junker; Jonathan Gershenzon; Sybille B Unsicker
Journal:  J Chem Ecol       Date:  2011-12-09       Impact factor: 2.626

3.  Simvastatin treatment shows no effect on the incidence of cerebral malaria or parasitemia during experimental malaria.

Authors:  Robin Kobbe; Nadine Schreiber; Jürgen May; Thomas Jacobs
Journal:  Antimicrob Agents Chemother       Date:  2008-02-11       Impact factor: 5.191

4.  Comparison of effects of different statins on growth and steroidogenesis of rat ovarian theca-interstitial cells.

Authors:  Anna Sokalska; Scott D Stanley; Jesus A Villanueva; Israel Ortega; Antoni J Duleba
Journal:  Biol Reprod       Date:  2014-02-27       Impact factor: 4.285

5.  Identification of luminal Loop 1 of Scap protein as the sterol sensor that maintains cholesterol homeostasis.

Authors:  Massoud Motamed; Yinxin Zhang; Michael L Wang; Joachim Seemann; Hyock Joo Kwon; Joseph L Goldstein; Michael S Brown
Journal:  J Biol Chem       Date:  2011-03-24       Impact factor: 5.157

6.  Novel effects of simvastatin on uterine fibroid tumors: in vitro and patient-derived xenograft mouse model study.

Authors:  Mostafa A Borahay; Kathleen Vincent; Massoud Motamedi; Elena Sbrana; Gokhan S Kilic; Ayman Al-Hendy; Darren Boehning
Journal:  Am J Obstet Gynecol       Date:  2015-03-31       Impact factor: 8.661

7.  Schoenheimer effect explained--feedback regulation of cholesterol synthesis in mice mediated by Insig proteins.

Authors:  Luke J Engelking; Guosheng Liang; Robert E Hammer; Kiyosumi Takaishi; Hiroshi Kuriyama; Bret M Evers; Wei-Ping Li; Jay D Horton; Joseph L Goldstein; Michael S Brown
Journal:  J Clin Invest       Date:  2005-08-11       Impact factor: 14.808

8.  Effect of lovastatin alone and as an adjuvant chemotherapeutic agent on hepatoma tissue culture-4 cell growth.

Authors:  T J Morris; S L Palm; L L Furcht; H Buchwald
Journal:  Ann Surg Oncol       Date:  1995-05       Impact factor: 5.344

9.  Simvastatin inhibits airway hyperreactivity: implications for the mevalonate pathway and beyond.

Authors:  Amir A Zeki; Lisa Franzi; Jerold Last; Nicholas J Kenyon
Journal:  Am J Respir Crit Care Med       Date:  2009-07-16       Impact factor: 21.405

10.  Treatment with apolipoprotein A-1 mimetic peptide reduces lupus-like manifestations in a murine lupus model of accelerated atherosclerosis.

Authors:  Jennifer M P Woo; Zhuofeng Lin; Mohamad Navab; Casey Van Dyck; Yvette Trejo-Lopez; Krystal M T Woo; Hongyun Li; Lawrence W Castellani; Xuping Wang; Noriko Iikuni; Ornella J Rullo; Hui Wu; Antonio La Cava; Alan M Fogelman; Aldons J Lusis; Betty P Tsao
Journal:  Arthritis Res Ther       Date:  2010-05-18       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.